NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter C. FarrellDirector2026-03-042,000$260.22
$520.44kSell
Brett SandercockChief Financial Officer2026-03-021,000$254.30
$254.30kSell
Michael J. FarrellChairman and CEO2026-02-094,991$273.78
$1.37MSell
Michael J. FarrellChairman and CEO2026-02-094,991$146.34
$730.38kBuy
Peter C. FarrellDirector2026-02-042,000$251.31
$502.62kSell
Michael J. RiderGlobal General Counsel2026-02-0450$260.00
$13.00kSell
Brett SandercockChief Financial Officer2026-02-021,000$257.03
$257.03kSell
Michael J. FarrellChairman and CEO2026-01-074,991$248.46
$1.24MSell
Peter C. FarrellDirector2026-01-072,000$248.83
$497.66kSell
Michael J. FarrellChairman and CEO2026-01-074,991$146.34
$730.38kBuy

1 of 9

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc12.96%18,882,403$4.77BInstitution
Blackrock Inc8.48%12,348,652$3.12BInstitution
State Street Corp4.55%6,625,408$1.68BInstitution
Bank Of New York Mellon Corp3.36%4,890,654$1.24BInstitution
Geode Capital Management LLC2.95%4,302,906$1.09BInstitution
Morgan Stanley1.98%2,891,697$731.22MInstitution
Invesco Ltd1.34%1,951,933$493.59MInstitution
Northern Trust Corp1.23%1,785,384$451.47MInstitution
Christopher G. Roberts1.17%1,700,337$429.96MInsider
First Trust Advisors LP1.04%1,517,592$383.75MInstitution

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD66.52%4.28%Net SellingNet Selling
ALC50.19%0.00%
BDX93.88%0.70%Net SellingNet Selling
WST96.23%3.77%Net SellingNet Selling
HOLX85.89%14.11%Net SellingNet Selling

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 66.52% institutional shareholders, 4.28% Resmed insiders, and 29.21% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.17% of the company. Christopher G. Roberts's Resmed shares are currently valued at $429.96M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.